CanReview is Canada’s new national single research ethics review system for multi-site clinical trials. Supported by the Accelerating Clinical Trials (ACT) Consortium, it empowers participating Research Ethics Boards (REBs) to conduct a single, high‑quality ethics review for trials spanning multiple Canadian sites — streamlining approval timelines, reducing duplication, and expanding access to research across all regions.